Torren Management »

Arrivent Biopharma shares owned by Torren Management

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Torren Management from 13F filings

Historical chart of Torren Management investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Torren Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Torren Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $760 33 23.06

More positions owned by Torren Management

Avantis Total Equity Markets Etf Etf (AVTM)
Avantis U.S. Equity ETF Etf (AVUS)
Avantis International Equity ETF Etf (AVDE)
Dimensional Short-Duration Fixed Income ETF Etf (DFSD)
Avantis U.S. Quality ETF Etf (AVUQ)
Dimensional Core Fixed Income ETF Etf (DFCF)
Avantis Emerging Markets Equity ETF Etf (AVEM)
Avantis U.S. Small Cap Value ETF Etf (AVUV)
Dimensional Global ex US Core Fixed Income ETF Etf (DFGX)
Dimensional Ultrashort Fixed Income ETF Etf (DUSB)
Dimensional US High Profitability ETF Etf (DUHP)
Dimensional International Core Equity 2 ETF Etf (DFIC)
PIMCO 15 Year U.S. TIPS Index ETF Etf (LTPZ)
Dimensional US Core Equity 2 ETF Etf (DFAC)
Dimensional International High Profitability ETF Etf (DIHP)

View all positions for Torren Management

Top funds holding Arrivent Biopharma

Suvretta Capital Management
Infinitum Asset Management
Hillhouse Capital Advisors
FMR
OrbiMed Advisors
BlackRock
Octagon Capital Advisors
Novo A/S
Vanguard Group
Sofinnova Ventures
Vanguard Capital Management
General Catalyst Group Management
State Street Corporation
Vivo Capital
Goldman Sachs Group

View all funds holding Arrivent Biopharma